Evidence map›Paper›PMID 42725355›Full record

ArticleGland surgery2026

Predictive model for increased postoperative drainage volume in patients with papillary thyroid carcinoma: a retrospective cohort study.

Weiben Ji, Ti Zhang, Mingzhen Chen, Yue Hu, Jianzhong Shi, Chunlan He, Shikun Ma

Abstract read
In one paragraph

Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Weiben Ji *Department of Breast and Thyroid Surgery, Yangzhou Hospital of Traditional Chinese Medicine, Yangzhou, China.ORCID https://orcid.org/0009-0007-5733-1280
Ti Zhang *Department of Breast and Thyroid Surgery, Yangzhou Hospital of Traditional Chinese Medicine, Yangzhou, China.
Mingzhen Chen *Department of Breast and Thyroid Surgery, Yangzhou Hospital of Traditional Chinese Medicine, Yangzhou, China.
Yue HuDepartment of Breast and Thyroid Surgery, Yangzhou Hospital of Traditional Chinese Medicine, Yangzhou, China.
Jianzhong ShiDepartment of Breast and Thyroid Surgery, Yangzhou Hospital of Traditional Chinese Medicine, Yangzhou, China.
Chunlan HeDepartment of Breast and Thyroid Surgery, Yangzhou Hospital of Traditional Chinese Medicine, Yangzhou, China.
Shikun MaDepartment of Breast and Thyroid Surgery, Yangzhou Hospital of Traditional Chinese Medicine, Yangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Papillary thyroid carcinoma (PTC) is the predominant type of thyroid cancer, with a rapidly increasing incidence worldwide. Surgery is the cornerstone of treatment for PTC. Postoperative placement of a negative-pressure drainage tube is commonly performed to prevent hematoma, seroma, and chyle leak. However, the timing for drain removal relies largely on the surgeon's own clinical judgment. There is no reliable model to help identify patients who face a higher risk of increased postoperative drainage output volume (DOV). Excessive DOV may lead to a prolonged hospital stay, increased patient discomfort, and a higher risk of infection. Therefore, we aim to develop a reliable predictive tool for postoperative DOV in patients with PTC. Methods: This retrospective study enrolled 171 patients with PTC who underwent surgery between July 2024 and May 2026. These patients were randomly assigned to training (n=120) and validation (n=51) cohorts in a 7:3 ratio. Univariable and multivariable logistic regression analyses were performed in the training cohort to identify independent risk factors for postoperative DOV in patients with PTC. A nomogram was constructed based on the independent risk factors. Receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA) were utilized to assess the predictive performance of the nomogram. Results: Patients were divided into high-output (HO, n=60) and low-output (LO, n=60) groups based on the median postoperative DOV. Univariable analysis revealed statistically significant differences between the groups in surgical time, number of tumors, number of central lymph node (LN) metastases (LNM), total number of LNs dissected, total number of LNM, scope of surgery, thyroid capsular invasion, and Hashimoto's thyroiditis (HT). Multivariable logistic regression analysis revealed that the total number of LNs dissected [odds ratio (OR) =1.125, 95% confidence interval (CI): 1.022-1.239, P=0.02], scope of surgery (OR =6.544, 95% CI: 1.445-29.64, P=0.02), and thyroid capsular invasion (OR =6.507, 95% CI: 1.63-25.975, P=0.008) were independent risk factors for increased postoperative DOV. The nomogram constructed based on these independent risk factors showed good discrimination in the internal validation cohort, with an area under the ROC curve (AUC) of 0.823 (95% CI: 0.746-0.901) in the training cohort and 0.849 (95% CI: 0.737-0.960) in the validation cohort. The calibration curve showed good agreement between the nomogram-predicted outcomes and the observed outcomes. DCA further confirmed its favorable clinical utility. Conclusions: We developed and validated a nomogram that integrates the total number of LNs dissected, scope of surgery, and thyroid capsular invasion. This model effectively predicts the likelihood of increased postoperative DOV and provides clinically useful guidance for drain management and recovery in patients with PTC. Nevertheless, these findings warrant further confirmation through large-scale, multicentre external validation studies before clinical implementation.

Indexed as

drainage output volume (DOV)nomogramPapillary thyroid carcinoma (PTC)thyroidectomy

Identifiers

PMID42725355
PMCPMC13561595

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.